Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Integrated serum metabolomics reveals severity-associated exploratory metabolic signatures in burn patients.

Frontiers in physiology·2026
Same author

Cholesterol-depleted macrophage membrane-coated nano-rapamycin for targeted atherosclerosis therapy.

Journal of nanobiotechnology·2026
Same author

Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Functional characterization of <b><i>KCNA5</i></b> gene variants linked to pulmonary arterial hypertension.

The European respiratory journal·2026
Same author

The effect of early tourniquet release on primary total knee arthroplasty and an analysis of risk factors for deep vein thrombosis.

The Knee·2026
Same author

The Danube Fish Database: documenting species distributions across a major European river basin.

Scientific data·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Michael J Spilka1, Mengdan Xu1, Balazs Toth2

  • 1Winterlight Labs (Cambridge Cognition), Toronto, ON, Canada.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
概括
此摘要是机器生成的。

数字语音生物标志物显示出跟踪阿尔茨海默病 (AD) 进展的前景. 之前开发的语音组合在临床试验中在测量随时间变化和可靠性方面表现最好.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

科学领域:

  • 神经学 神经学
  • 计算语言学 计算语言学
  • 生物标志物 生物标志物

背景情况:

  • 阿尔茨海默病 (AD) 的特点是语言逐渐衰退.
  • 自然语言处理 (NLP) 为测量语言障碍提供了客观的工具.
  • 语音生物标志物可以促进跟踪AD的临床进展.

研究的目的:

  • 评估和比较基于数字语音的标记,用于跟踪阿尔茨海默病的进展.
  • 评估语音复合材料在测量纵向变化和可靠性的性能.
  • 在AD试验中将语音生物标志物与已确定的临床终点相关联.

主要方法:

  • 临床痴呆症评分 (CDR) 采访记录的分析,来自于2个2期2期semorinemab试验的227名参与者的采访记录.
  • 从患者的反应计算声学和语言语音特征.
  • 使用不同的特征选择方法开发和验证三个语音复合分数.

主要成果:

  • 这三种语音组合均显示出随时间的推移显著的纵向变化 (效果大小为0.47-0.59).
  • 对复合材料观察到足够的测试重复测试可靠性 (类内相关性为0.67-0.80).
  • 复合物与ADAS-Cog11和CDR-SB (斯皮尔曼 rho 0.21-0.49) 等临床终点有显著的相关性.

结论:

  • 语音特征可以整合到对轻度认知障碍 (MCI) 到中度AD疾病进展的有意义指数中.
  • 之前发表的Tauriel衍生生物标志物复合物表现最好,显示了最大的效果大小,最高的可靠性和节性.
  • 基于语音的生物标志物提供了一个潜在的客观,低负担的措施,以补充AD临床试验中的传统终点.